Stage IS Testicular Cancer clinical trials at UC Cancer

• A Study of miRNA 371 in Patients With Germ Cell Tumors

  open to eligible people ages 18 years and up

  This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

  at UC Irvine UCSD

Last updated: September 29, 2020